CoChat
Sign Up
Cited by 865Healthcare Systems and Public HealthCardiovascular Health and Risk FactorsGlobal Health and Epidemiology

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Mortality From Ischemic Heart Disease: Analysis of Data From the World Health Organization and Coronary Artery Disease Risk Factors From NCD Risk Factor Collaboration

Open access
Nowbar, Alexandra N., Gitto, Mauro, Howard, James P., Francis, Darrel P., Al-Lamee, Rasha·2019·Circulation: Cardiovascular Quality and Outcomes
DOI 10.1161/circoutcomes.118.005375PMC PMC6613716
Open this paper in CoChat — free account

Abstract

Background: Ischemic heart disease (IHD) has been considered the top cause of mortality globally. However, countries differ in their rates and there have been changes over time. Methods and Results: We analyzed mortality data submitted to the World Health Organization from 2005 to 2015 by individual countries. We explored patterns in relationships with age, sex, and income and calculated age-standardized mortality rates for each country in addition to crude death rates. In 5 illustrative countries which provided detailed data, we analyzed trends of mortality from IHD and 3 noncommunicable diseases (lung cancer, stroke, and chronic lower respiratory tract diseases) and examined the simultaneous trends in important cardiovascular risk factors. Russia, United States, and Ukraine had the largest absolute numbers of deaths among the countries that provided data. Among 5 illustrative countries (United Kingdom, United States, Brazil, Kazakhstan, and Ukraine), IHD was the top cause of death, but mortality from IHD has progressively decreased from 2005 to 2015. Age-standardized IHD mortality rates per 100 000 people per year were much higher in Ukraine (324) and Kazakhstan (97) than in United States (60), Brazil (54), and the United Kingdom (46), with much less difference in other causes of death. All 5 countries showed a progressive decline in IHD mortality, with a decline in smoking and hypertension and in all cases a rise in obesity and type II diabetes mellitus. Conclusions: IHD remains the single largest cause of death in countries of all income groups. Rates are different between countries and are falling in most countries, indicating great potential for further gains. On the horizon, future improvements may become curtailed by increasing hypertension in some developing countries and more importantly global growth in obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circoutcomes.118.005375

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Changes in (A) crude death rates and (B) age-standardized mortality rates between 2005 and 2015. These are the 16 countries who provided longitudinal mortality data.
Figure 1. Changes in (A) crude death rates and (B) age-standardized mortality rates between 2005 and 2015. These are the 16 countries who provided longitudinal mortality data.CC BY · PubMed Central
Figure 2. Variation in age- and sex-specific mortality in (A) United Kingdom, (B) Brazil, (C) United States, (D) Kazakhstan, and (E) Ukraine. All data are from 2015 except Kazakhstan which is from 2012.
Figure 2. Variation in age- and sex-specific mortality in (A) United Kingdom, (B) Brazil, (C) United States, (D) Kazakhstan, and (E) Ukraine. All data are from 2015 except Kazakhstan which is from 2012.CC BY · PubMed Central
Figure 3. Mortality trends from major causes of death from 2005 to 2015 in (A) United Kingdom, (B) Brazil, (C) United States, (D) Kazakhstan, and (E) Ukraine. Age-standardized mortality rates per 100 000 people from ischemic heart disease (red line), stroke (light blue line), cirrhosis and other liver diseases (green line), chronic lower respiratory tract diseases (yellow line), lung cancer (blue line), transport accidents (orange line), and infectious diseases (purple line).
Figure 3. Mortality trends from major causes of death from 2005 to 2015 in (A) United Kingdom, (B) Brazil, (C) United States, (D) Kazakhstan, and (E) Ukraine. Age-standardized mortality rates per 100 000 people from ischemic heart disease (red line), stroke (light blue line), cirrhosis and other liver diseases (green line), chronic lower respiratory tract diseases (yellow line), lung cancer (blue line), transport accidents (orange line), and infectious diseases (purple line).CC BY · PubMed Central
Figure 4. Mortality trends from ischemic heart disease (IHD) compared with variations in Gross National Income (GNI) and prevalence of cardiovascular risk factors from 2005 to 2015 in (A) United Kingdom, (B) Brazil, (C) United States, (D) Kazakhstan, and (E) Ukraine. The red line and right axis represent the IHD mortality trend. Behind this are a family of area charts showing trends of GNI (yellow), age-standardized mean body mass index (BMI; purple), age-standardized prevalence of smoking (green), type II diabetes mellitus (DM II; light blue), and hypertension (HTN; orange).
Figure 4. Mortality trends from ischemic heart disease (IHD) compared with variations in Gross National Income (GNI) and prevalence of cardiovascular risk factors from 2005 to 2015 in (A) United Kingdom, (B) Brazil, (C) United States, (D) Kazakhstan, and (E) Ukraine. The red line and right axis represent the IHD mortality trend. Behind this are a family of area charts showing trends of GNI (yellow), age-standardized mean body mass index (BMI; purple), age-standardized prevalence of smoking (green), type II diabetes mellitus (DM II; light blue), and hypertension (HTN; orange).CC BY · PubMed Central
Figure 5. Statin prescription rates in the United Kingdom from 2005 to 2013. Rates of prescription in the population over 18 y old.
Figure 5. Statin prescription rates in the United Kingdom from 2005 to 2013. Rates of prescription in the population over 18 y old.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

Sorted by citations

Items 301–400 of 865

Related

See all

Metadata

Authors
Nowbar, A. N., Gitto, M., Howard, J. P., Francis, D. P., & Al-Lamee, R.
Affiliations
  • Hammersmith Hospital (GB)
  • International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College London, Hammersmith Hospital, London, United Kingdom (A.N.N., M.G., J.P.H., D.P.F., R.A.-L.).
Corresponding author
Nowbar, Alexandra N.
ORCID
Venue
Circulation: Cardiovascular Quality and Outcomes
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2019-06
Volume
12
Issue
6
Pages
e005375-e005375
ISSN
  • 1941-7705 (ISSN-L)
  • 1941-7713
DOI
10.1161/circoutcomes.118.005375
PMC
PMC6613716
OpenAlex
W2950663303
Cited by
860
References
20
Citations by year
2026: 58 · 2025: 121 · 2024: 149 · 2023: 155 · 2022: 147 · 2021: 133 · 2020: 83 · 2019: 12
FWCI
71.55
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Circulation Cardiovascular Quality and Outcomes (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by)
Funders
  • Wellcome Trust (212183/Z/18/Z)
  • National Institute for Health and Care Research
Topics
  • Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Health and Epidemiology
Keywords
ischemic heart disease, mortality trends, age-standardized mortality rates, non-communicable diseases, lung cancer, stroke, cardiovascular risk factors, smoking, hypertension, obesity, type 2 diabetes, income inequality, sex differences, global burden of disease
MeSH terms
Adult, Aged, Aged, 80 and over, Cause of Death, Diabetes Mellitus, Female, Humans, Hypertension, Male, Middle Aged, Obesity, Risk Factors, Smoking, Time Factors, Global Health, World Health Organization, Comorbidity, Prevalence, Myocardial Ischemia, Age Distribution, Sex Distribution, Risk Assessment, Health Status Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review